Mariner’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,822
Closed -$1.87M 3216
2023
Q3
$1.87M Buy
8,822
+697
+9% +$139K 0.01% 1003
2023
Q2
$1.56M Sell
8,125
-2,225
-21% -$442K ﹤0.01% 1076
2023
Q1
$2.1M Buy
10,350
+675
+7% +$108K 0.01% 935
2022
Q4
$1.24M Sell
9,675
-1,447
-13% -$187K ﹤0.01% 1139
2022
Q3
$1.52M Buy
11,122
+850
+8% +$138K 0.01% 879
2022
Q2
$1.82M Buy
+10,272
New +$1.48M 0.01% 736
2019
Q3
Sell
-23,593
Closed -$1.63M 1078
2019
Q2
$1.63M Buy
+23,593
New +$1.65M 0.02% 430
2018
Q2
Sell
-12,778
Closed -$669K 829
2018
Q1
$669K Buy
+12,778
New +$696K 0.02% 389

Other funds holding SGEN

Mariner's SGEN Position: Q4 2023 in Review

Mariner sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 8,822 shares — an estimated $1.87M sold.

Mariner first reported a position in SGEN in Q1 2018 and held it in 8 quarters. The position peaked at $2.1M in Q1 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Mariner reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Mariner sold 8,822 Seagen Inc. Common Stock shares in Q4 2023, an estimated $1.87M.
  • Mariner first reported a position in Seagen Inc. Common Stock in Q1 2018 and held it in 8 quarters.
  • Mariner's Seagen Inc. Common Stock position peaked at $2.1M in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Mariner's 13F filing for Q4 2023, filed 14 Feb 2024.